Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Efficacy of oral 2-DG in comparison to placebo in preventing worsening of COVID-19 clinical disease severity; in RT-PCR confirmed SARS-CoV-2 patients having mild COVID-19 disease; when administered as adjunctive treatment to standard of care managementTimepoint: Randomization to Day 14	Efficacy of oral 2-DG in comparison to placebo in preventing worsening of COVID-19 clinical disease severity; in RT-PCR confirmed SARS-CoV-2 patients having mild COVID-19 disease; when administered as adjunctive treatment to standard of care managementTimepoint: Randomization to Day 14
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	Efficacy of oral 2-DG in comparison to placebo in preventing worsening of COVID-19 clinical disease severity; in RT-PCR confirmed SARS-CoV-2 patients having mild COVID-19 disease; when administered as adjunctive treatment to standard of care managementTimepoint: Randomization to Day 14	Efficacy of oral 2-DG in comparison to placebo in preventing worsening of COVID-19 clinical disease severity; in RT-PCR confirmed SARS-CoV-2 patients having mild COVID-19 disease; when administered as adjunctive treatment to standard of care managementTimepoint: Randomization to Day 14